GranuFlo Recall Website Launched By Hissey Kientz, LLP Law Firm

The law firm of Hissey Kientz, LLP is announcing the launch of its new website, GranuFlo Recall Help (http://www.granuflorecallhelp.com/). The Food and Drug Administration issued a Class 1 recall of all GranuFlo and NaturaLyte dialysis products after the dialysate acid concentrates were linked to severe complications such as heart attack, stroke and sudden cardiac death.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

The law firm of Hissey Kientz, LLP represents victims of GranuFlo, NaturaLyte and other potentially dangerous products.

Fresenius Medical Care warned that patients with elevated bicarbonate levels were six times more likely to suffer a heart attack or sudden cardiac death from GranuFlo or NaturaLyte than patients using other dialysis products.

Austin, Texas (PRWEB) January 21, 2013

The law firm of Hissey Kientz, LLP is announcing the launch of its new website, GranuFlo Recall Help (http://www.granuflorecallhelp.com/). The site will serve as a source for news and legal information for patients and their families who have experienced side effects after receiving hemodialysis treatment with GranuFlo or NaturaLyte dialysate concentrates.

The Food and Drug Administration (FDA) issued a Class 1 Recall of GranuFlo dry acid concentrate and NaturaLyte liquid acid concentrate in March 2012 after it was presented with a leaked internal memo from GranuFlo and NaturaLyte manufacturer Fresenius Medical Care (FMC).

GranuFlo and NaturaLyte acid concentrates contain bicarbonate, which is used during hemodialysis treatment to neutralize acid build up in the blood. When patients have elevated pre-dialysis bicarbonate blood levels, the addition of GranuFlo or NaturaLyte could raise bicarbonate levels to dangerous heights, resulting in serious side effects such as heart attack, stroke or sudden death.

In their November 2011 internal memo, Fresenius Medical Care warned that patients with elevated bicarbonate levels were six times more likely to suffer a heart attack or sudden cardiac death from GranuFlo or NaturaLyte than patients using other dialysis products. Fresenius also reported that 941 patients had experienced sudden cardiac arrest within their dialysis clinics in 2010 after undergoing hemodialysis treatment with GranuFlo or NaturaLyte.

According to The New York Times, Fresenius Medical Care issued this memo to dialysis centers owned by Fresenius, but did not warn thousands of non-Fresenius owned dialysis clinics using GranuFlo and NaturaLyte products until March 2012.

Patients who have experienced heart attack, stroke, or other injuries after being treated with GranuFlo or NaturaLyte may wish to speak with a lawyer to find out if they are eligible to file a lawsuit. For more information about whether you may have a case, contact the attorneys at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454, or by email at info(at)hkllp(dot)com

About Hissey Kientz, LLP
Hissey Kientz, LLP (http://www.hkllp.com) represents individuals affected by the side effects of GranuFlo and NaturaLyte, as well as victims of mesothelioma and other asbestos-related diseases, birth defects linked to the antidepressant drugs Zoloft, Lexapro, Celexa, Paxil and Effexor, problems with transvaginal mesh, DePuy ASR and Pinnacle hip replacements, Actos bladder cancer, birth defects caused by Topamax and other defective drugs and medical devices.


Contact

  • Allison Sass
    Hissey Kientz, LLP
    (512) 320-9100
    Email
Follow us on: Contact's Facebook Contact's Twitter Contact's LinkedIn Contact's Google Plus